Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
12.57
-0.07 (-0.55%)
At close: Dec 19, 2025, 4:00 PM EST
12.66
+0.09 (0.72%)
After-hours: Dec 19, 2025, 7:55 PM EST
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 8,300 employees as of December 31, 2024. The number of employees increased by 450 or 5.73% compared to the previous year.
Employees
8,300
Change (1Y)
450
Growth (1Y)
5.73%
Revenue / Employee
$353,610
Profits / Employee
$711
Market Cap
3.95B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8,300 | 450 | 5.73% |
| Dec 31, 2023 | 7,850 | 250 | 3.29% |
| Dec 31, 2022 | 7,600 | 600 | 8.57% |
| Dec 31, 2021 | 7,000 | 1,000 | 16.67% |
| Dec 31, 2020 | 6,000 | 500 | 9.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AMRX News
- 2 days ago - Amneal: Growing Drug Portfolio, Positive Cash Flow, Outweighing Leverage Risks - Seeking Alpha
- 10 days ago - Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals - GlobeNewsWire
- 14 days ago - Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson's Disease - GlobeNewsWire
- 17 days ago - Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol - GlobeNewsWire
- 17 days ago - Amneal to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 18 days ago - Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05% - GlobeNewsWire
- 5 weeks ago - Amneal Receives U.S. FDA Approval for Iohexol Injection - GlobeNewsWire
- 7 weeks ago - Amneal Pharmaceuticals, Inc. (AMRX) Q3 2025 Earnings Call Transcript - Seeking Alpha